Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Platform entities : Eli lilly and company save search
ProQR Highlights New Platform Data from Presentation on Axiomer™ RNA Editing Technology at Deaminet 2024
Published: 2024-01-19 (Crawled : 12:00) - globenewswire.com
LLY | $746.74 -0.54% 1.01% 2.5M
|
Health Technology
|
| O: -0.15%
H: 1.16%
C: 0.99%
PRQR | $2.01 -1.71% -1.74% 220K
|
Health Technology
|
| O: 2.36%
H: 2.76%
C: -4.15%
presentation technology platform
Fauna Bio Announces Strategic Collaboration with Lilly to Discover Novel Obesity Targets Using Convergence™ AI Platform
Published: 2023-12-21 (Crawled : 15:00) - biospace.com/
LLY | $746.74 -0.54% 1.01% 2.5M
|
Health Technology
|
| O: 0.21%
H: 0.63%
C: 0.1%
obesity collaboration platform
ProQR Announces Initial Pipeline Targets and Highlights Axiomer® RNA Editing Platform Technology at R&D Event
Published: 2023-03-29 (Crawled : 12:20) - globenewswire.com
LLY | $746.74 -0.54% 1.01% 2.5M
|
Health Technology
|
| O: 0.4%
H: 0.23%
C: -0.92%
PRQR | $2.01 -1.71% -1.74% 220K
|
Health Technology
|
| O: -10.34%
H: 1.56%
C: -21.5%
axiomer pipeline technology platform
ProQR Announces Conference Call to Discuss Axiomer® RNA Editing Platform
Published: 2022-12-22 (Crawled : 12:00) - globenewswire.com
LLY | $746.74 -0.54% 1.01% 2.5M
|
Health Technology
|
| O: -0.19%
H: 0.66%
C: -0.55%
PRQR | $2.01 -1.71% -1.74% 220K
|
Health Technology
|
| O: 64.85%
H: 13.97%
C: -0.74%
axiomer conference platform
Lilly to begin rollout of Tempo® Personalized Diabetes Management Platform
Published: 2022-11-07 (Crawled : 17:00) - prnewswire.com
LLY | $746.74 -0.54% 1.01% 2.5M
|
Health Technology
|
| O: 0.17%
H: 2.51%
C: 1.97%
DXCM | $136.51 1.45% 1.43% 3M
|
Health Technology
|
| O: 0.92%
H: 0.6%
C: -0.53%
tempo management diabetes platform
Schrödinger Hosts Platform Day
Published: 2022-10-06 (Crawled : 12:00) - biospace.com/
LLY | $746.74 -0.54% 1.01% 2.5M
|
Health Technology
|
| O: -1.16%
H: 3.45%
C: 1.53%
SDGR | $24.78 -2.98% -3.07% 550K
|
Technology Services
|
| O: 0.42%
H: 2.35%
C: -3.49%
day platform
Genesis Therapeutics Announces Strategic Collaboration with Lilly to Discover Novel Therapies Using the Genesis Molecular AI Platform
Published: 2022-05-03 (Crawled : 12:00) - biospace.com/
LLY | $746.74 -0.54% 1.01% 2.5M
|
Health Technology
|
| O: -1.31%
H: 0.0%
C: 0.0%
collaboration therapeutics molecular platform therapy
ImmunoGen Announces a Global, Multi-Target License Agreement of its Novel Camptothecin ADC Platform to Lilly for Up to $1.7 Billion
Published: 2022-02-15 (Crawled : 13:00) - biospace.com/
LLY | $746.74 -0.54% 1.01% 2.5M
|
Health Technology
|
| O: 0.84%
H: 3.44%
C: 3.04%
IMGN | $31.23 0.03% 49M
|
Health Technology
|
| O: 2.53%
H: 5.43%
C: 2.11%
license platform
Lilly and Foghorn Announce Strategic Collaboration for Novel Oncology Targets Using Foghorn’s Proprietary Gene Traffic Control® Platform
Published: 2021-12-13 (Crawled : 12:00) - biospace.com/
LLY | $746.74 -0.54% 1.01% 2.5M
|
Health Technology
|
| O: 1.27%
H: 0.0%
C: 0.0%
FHTX | $6.09 -4.7% -4.93% 87K
|
Health Technology
|
| O: 51.84%
H: 0.0%
C: 0.0%
control collaboration platform
Gainers vs Losers
| 58% | 42% |
Top 10 Gainers
WISA 4 | $6.06 246.29% 71.12% 200M
|
Electronic Technology
VIAO | $0.265 -13.96% 35.85% 960K
|
Electronic Technology
JAGX | $0.178 49.83% 33.26% 600M
|
Health Technology
SXTC | $1.68 43.59% 30.36% 34M
|
Health Technology
DYNT | $0.531 43.36% 30.24% 22M
|
Health Technology
KA | $0.4796 41.06% 29.11% 5.3M
|
Manufacturing
PALI | $5.86 40.87% 29.01% 29M
|
Manufacturing
CLNN | $0.319 -3.74% 28.75% 6.3M
|
BSGM | $1.52 38.18% 27.63% 3.3M
|
Health Technology
MCBC | $13.67 37.66% 27.36% 2.2M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.